drug · small molecule

namodenoson

Phase 3updated 3mo ago

by $CANF Can-Fite BioPharma Ltd.🔗 ChEMBL

Phase 3

community read0 votes

Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 5 investigational indications.

targets

Adenosine receptor A3

all catalysts(0)

nothing on the calendar yet

Trials studying namodenoson

phase3Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosisrecruitingn=471
phase2Namodenoson Treatment of Advanced Pancreatic Cancerrecruitingn=20
phase2Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)recruitingn=114

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 32m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · small molecule

save

namodenoson

Phase 3updated 3mo ago

by $CANF Can-Fite BioPharma Ltd.🔗 ChEMBL

Phase 3

community read0 votes

Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 5 investigational indications.

targets

Adenosine receptor A3

all catalysts(0)

nothing on the calendar yet

Trials studying namodenoson

phase3Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosisrecruitingn=471
phase2Namodenoson Treatment of Advanced Pancreatic Cancerrecruitingn=20
phase2Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)recruitingn=114

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 32m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

namodenoson

targets

all catalysts(0)

Trials studying namodenoson

News(0)

Report a data issue

comments(0)

namodenoson

targets

all catalysts(0)

Trials studying namodenoson

News(0)

Report a data issue

comments(0)